A Study of a Personalized Neoantigen Cancer Vaccine

Clinical trial NCT03639714 · COMPLETED

Trial details

NCT number: NCT03639714
Sponsor: Gritstone bio, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Colorectal Cancer Gastroesophageal Adenocarcinoma Urothelial Carcinoma

Start date: 2019-02-13
Primary completion: 2022-11-10
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.